Abstract
Oocyte cryopreservation is the mainstay of fertility preservation in patients with malignancy; however, live birth rates after oocyte cryopreservation are lower in cancer patients than in healthy patients. Multiple modalities of fertility preservation can be combined to optimize success rates. We demonstrate a case of a 24-year-old female who was diagnosed with cervical clear cell adenocarcinoma and was advised to undergo treatment with cisplatin and radiation therapy. She strongly desired fertility preservation and opted to proceed with oocyte cryopreservation, ovarian tissue cryopreservation, and ovarian transposition. Ovarian transposition is a surgical approach to fertility preservation that preserves both fertility and gonadal function. Different modes of fertility preservation may be combined to optimize live birth rates in patients with malignancy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
